Financial report interval: 2024.12.31 - 2025.12.31
Overview: INNOGEN-B(02591) the Revenue is 146.24 M (--%), Beat estimate;the EBIT is -381.17 M (--%), Miss estimate;the EPS is -0.879 (--%), Miss estimate.